SEC Form D · filed August 12, 2020
RespireRx Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Timothy E. Jones · Glen Rock, NJExec · DirectorRichard E. Purcell · Glen Rock, NJExecMatt Harris · New York, NYDirectorPeter Mullen · New York, NYDirectorLuke J. Atwood · Richmond, VAExec · DirectorChristine K. Funk · Sisters, ORExecDonald R. Mclamb, Jr · Wilmington, DEExecGlenn R. Hanson · Wilbraham, MAExec · DirectorJeff E. Margolis · Glen Rock, NJExec · DirectorWilliam S. Seybold · San Fransisco, CAExec · DirectorRichard Ferrari · Los Gatos, CAExec · DirectorArnold S. Lippa · Glen Rock, NJExec · DirectorCharles Berg · New York, NYExec · DirectorAndrew F. St Pierre · Burlington, MAExec · DirectorKathryn E. Macfarlane · Glen Rock, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗